Corrections & Amplifications
This article was corrected at 0547 GMT to reflect the proper term of Ebita. The original headline referred to it as Ebitda.
By Ian Walker
Royal Philips raised its full-year guidance after swinging to net profit for the third quarter of the year on higher sales, with growth in all segments and geographies.
The Dutch health-technology company said Monday that it now expects to report a 6% to 7% rise in comparable sales this year compared with previous guidance for mid-single-digit comparable growth.
Adjusted earnings before interest, taxes and amortization margin is seen at 10% to 11% compared with previous guidance at the upper end of the high-single-digit range for 2023.
Write to Ian Walker at [email protected]
Read the full article here